Medicare Enrolled

Dr. Mark Yoffe, M.D.

Hematology & Oncology · Raleigh, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2605 BLUE RIDGE RD STE 190, Raleigh, NC 27607
9197846060
Registered in NPPES since 2006
NPI: 1770523227 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yoffe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yoffe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yoffe

Dr. Mark Yoffe is a hematology & oncology specialist in Raleigh, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Yoffe performed 233 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Yoffe received a total of $5,603 from 24 pharmaceutical and/or device companies across 37 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yoffe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 233 Medicare services $5,603 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
233
Medicare services
Bottom 28% in NC for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 166 $78 $278
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
 67 $131 $388
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2023 ↗
$5,603
Total received (2018-2023)
Avg $934/year across 6 years
Top 31% in NC for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
37
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$409
2022
$1,765
2021
$408
2020
$211
2019
$971
2018
$1,839

Payments by company (2023)

Janssen Biotech, Inc.
$130
Regeneron Healthcare Solutions, Inc.
$126
BeiGene USA, Inc.
$125
Incyte Corporation
$28
Top 3 companies account for 93.2% of 2023 payments
All-time payments by company (2018-2023) ›
Genentech USA, Inc.
$1,765
Seattle Genetics, Inc.
$1,130
Janssen Biotech, Inc.
$325
Celgene Corporation
$298
AstraZeneca Pharmaceuticals LP
$250
Merck Sharp & Dohme Corporation
$153
Regeneron Healthcare Solutions, Inc.
$126
Bayer HealthCare Pharmaceuticals Inc.
$125
BeiGene USA, Inc.
$125
Novartis Pharmaceuticals Corporation
$122
GENZYME CORPORATION
$121
Medical Device Business Services, Inc.
$114
TESARO, Inc.
$111
Cook Medical LLC
$107
Alexion Pharmaceuticals, Inc.
$103
COMSORT, Inc
$100
Takeda Pharmaceuticals U.S.A., Inc.
$90
PFIZER INC.
$86
Epizyme, Inc.,
$80
Lilly USA, LLC
$77
Seagen Inc.
$77
Puma Biotechnology, Inc.
$60
Incyte Corporation
$48
Gilead Sciences, Inc.
$12
Top 3 companies account for 57.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Abraxane · BRUKINSA · CERTUS 140 MICROWAVE ABLATION SYSTEM · Cook Medical AAA · ERLEADA · IBRANCE · IMBRUVICA · Inrebic · JAKAFI · KEYTRUDA · KISQALI · LIBTAYO · MONJUVI · NERLYNX · NINLARO · POLIVY · SOLIRIS · TAGRISSO · TAZVERIK · TECVAYLI · VERZENIO · Xofigo · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Raleigh?
Compare hematology & oncology specialists in the Raleigh area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
86
County median income
$101,763
Nearest hospital to ZIP centroid (approximate)
REX HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2023
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yoffe is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yoffe experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Yoffe performed 166 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Yoffe receive payments from pharmaceutical companies?
Yes. Dr. Yoffe received a total of $5,603 from 24 companies across 37 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yoffe's costs compare to other hematology & oncology specialists in Raleigh?
Dr. Yoffe's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yoffe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Hematology & Oncology Specialists in Raleigh
Browse hematology & oncology specialists in Raleigh ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NC
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NC
Which NC hematology & oncology specialists receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Seattle Genetics, Inc. Payments to Doctors
See all physicians who received payments from Seattle Genetics, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →